<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABB</journal-id><journal-title-group><journal-title>Advances in Bioscience and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2156-8456</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abb.2016.79033</article-id><article-id pub-id-type="publisher-id">ABB-69947</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Copper Ions Enhance Signal Intensity of Sandwich ELISA for Amorphous Aggregates of Amyloid-β&lt;sub&gt;42&lt;/sub&gt;
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akira</surname><given-names>Itakura</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoshio</surname><given-names>F. Kanematsu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ryoko</surname><given-names>Suzuki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hideki</surname><given-names>Kohno</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kazuaki</surname><given-names>Yoshimune</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Applied Molecular Chemistry, Graduate School of Industrial Technology, Nihon University, Chiba, Japan</addr-line></aff><aff id="aff2"><addr-line>Hoshi University, Tokyo, Japan</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>08</month><year>2016</year></pub-date><volume>07</volume><issue>09</issue><fpage>343</fpage><lpage>349</lpage><history><date date-type="received"><day>June</day>	<month>16,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>August</month>	<year>19,</year>	</date><date date-type="accepted"><day>August</day>	<month>22,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Amyloid-β
  <sub>42</sub> (Aβ
  <sub>42</sub>) accumulates within senileplaque, a pathological hall mark of Alzheimer’s disease (AD). Our previous reports showed that the monoclonal antibodies 37-11 and 77-3 react with conformational epitopes on the surface of the soluble aggregates of Aβ
  <sub>42</sub> and that sandwich ELISA using these two monoclonal antibodies yields high reactivity to detect soluble aggregates of Aβ
  <sub>42</sub>. Here, the reactivity of the sandwich ELISA was shown to increase in the presence of 50 μM Cu
  <sup>2+</sup>. However, the addition of Cu
  <sup>2+</sup> had only a small effect on the reactivity of a direct ELISA using antibody 37-11 or 77-3, suggesting that Cu
  <sup>2+</sup> has a small effect on the number of epitopes on the surface of the aggregates. Atomic force microscopy images showed that larger aggregates were formed in the presence of Cu
  <sup>2+</sup>, as shown in the other reports. Cu
  <sup>2+</sup> may gather the aggregates with distinct epitopes recognized by antibodies 37-11 and 77-3, leading to increased signal intensity of the sandwich ELISA.
 
</p></abstract><kwd-group><kwd>Amyloid-β&lt;sub&gt;42&lt;/sub&gt;</kwd><kwd> Soluble Aggregates</kwd><kwd> Antibody</kwd><kwd> ELISA</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>One of major hallmarks of Alzheimer’s disease (AD) is the formation of senile plaques, mainly consisting of amyloid beta protein (Aβ), in the brains of patients [<xref ref-type="bibr" rid="scirp.69947-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.69947-ref2">2</xref>] . Under physiological conditions, Aβ are produced by the partial digestions of amyloid precursor proteins; most Aβs consist of 40 amino acids (Aβ<sub>40</sub>), though approximately 10% are 42 amino acids in length (Aβ<sub>42</sub>) [<xref ref-type="bibr" rid="scirp.69947-ref3">3</xref>] . Aβ<sub>42</sub> has higher hydrophobicity, and thus a higher tendency to aggregate compared to Aβ<sub>40</sub>; therefore, Aβ<sub>42</sub> appears to be the more toxic variant [<xref ref-type="bibr" rid="scirp.69947-ref4">4</xref>] . Aβ<sub>42</sub> forms two distinct aggregates known as fibrillar and amorphous forms. The fibrillar form has an antiparallel β-sheet structure, and is the main component of senile plaques [<xref ref-type="bibr" rid="scirp.69947-ref5">5</xref>] . The fibril formation is formed from the conversion of monomers to oligomers and subsequently to protofibrils and fibrils [<xref ref-type="bibr" rid="scirp.69947-ref6">6</xref>] . The amorphous aggregates are less structured and lack the ability to form fibrils. They are found in diffuse plaques [<xref ref-type="bibr" rid="scirp.69947-ref7">7</xref>] and senile plaques in the brains of AD patients [<xref ref-type="bibr" rid="scirp.69947-ref8">8</xref>] . Various sizes of amorphous aggregates have been reported ranging from trimers to sub-micrometer orders [<xref ref-type="bibr" rid="scirp.69947-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.69947-ref11">11</xref>] . Large oval aggregates (LOA), which are amorphous aggregates greater than 200 nm in their minor axis, are generated by the addition of peptide Aβ<sub>16-20</sub> [<xref ref-type="bibr" rid="scirp.69947-ref12">12</xref>] . Aβ<sub>16-20</sub> includes the region essential for the fibril formation in Aβ but prevents fibril formation to produce LOAs. As previously described [<xref ref-type="bibr" rid="scirp.69947-ref13">13</xref>] , soluble aggregates are prepared by dissolving Aβ<sub>42</sub> in 1,1,1,3,3,3-hexafluoro-2-propanol in the absence of Aβ<sub>16-20</sub>. The soluble aggregates include various sizes of amorphous aggregates ranging from 20 to 400 nm. Metal ions such as Cu<sup>2+</sup> bind to Aβ affecting the formation of aggregates. Many reports show that Cu<sup>2+</sup> binding changes the surface charge of Aβ and enhances amorphous aggregate formation by preventing fibril formation [<xref ref-type="bibr" rid="scirp.69947-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.69947-ref18">18</xref>] . Aβ<sub>42</sub> in cerebrospinal fluid (CSF) is a clinical biomarker for AD [<xref ref-type="bibr" rid="scirp.69947-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.69947-ref20">20</xref>] . In AD patients, the concentration of Aβ<sub>42</sub> decreases, as it is incorporated into senile plaques, whereas the concentration of Aβ<sub>40</sub> is unchanged. The average concentration of Aβ<sub>42</sub> in spinal fluid is less than 200 Pm [<xref ref-type="bibr" rid="scirp.69947-ref19">19</xref>] . Therefore, highly sensitive detection of Aβ<sub>42</sub> is desirable for AD diagnosis. Our previous reports identified various monoclonal antibodies with reactivity against Aβ aggregates, but with little reactivity against the fibril and monomer forms [<xref ref-type="bibr" rid="scirp.69947-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.69947-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.69947-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.69947-ref21">21</xref>] . Among them, antibody 37-11 was determined to react with LOA [<xref ref-type="bibr" rid="scirp.69947-ref12">12</xref>] , and antibody 77-3 could react with both LOA and soluble aggregates [<xref ref-type="bibr" rid="scirp.69947-ref13">13</xref>] . Sandwich ELISA using these two antibodies resulted in the highly sensitive detection of soluble aggregates. In this report, the reactivity of the sandwich ELISA was shown to increase through the addition of 50 μM Cu<sup>2+</sup>; however, the addition had only a small effect on the reactivity of each antibody. Cu<sup>2+</sup> could gather aggregates to form large aggregates with two distinct epitopes that were specifically recognized by antibodies 77-3 and 37-11.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Preparation of the Soluble Aggregates</title><p>Soluble amorphous aggregates were prepared as previously described [<xref ref-type="bibr" rid="scirp.69947-ref21">21</xref>] . Briefly, 0.11 mM Aβ<sub>42</sub> (Peptide Institute Inc., Osaka, Japan) was dissolved in 1,1,1,3,3,3-hexafluo- ro-2-propanol, and incubated at 4˚C for 16 h followed by 37˚C for 3 h, after which the solution was lyophilized. The steps including dissolution and lyophilization were repeated twice, and lyophilized Aβ<sub>42</sub> was dissolved in deionized water. The concentration of Aβ<sub>42</sub> in the solution was determined by its absorbance at 280 nm using the molar extinction coefficient of 1450 M<sup>−1</sup>cm<sup>−1</sup> of Aβ<sub>42</sub>, which has one tyrosine residue and no tryptophan residues.</p></sec><sec id="s2_2"><title>2.2. Enzyme-Linked Immunosorbent Assay (ELISA)</title><p>Direct ELISA was performed as previously described [<xref ref-type="bibr" rid="scirp.69947-ref12">12</xref>] . The soluble aggregates (100 μl) were used as solid-phase antigens, and were stained on 96-well plates (F96 MAXISORP NUNC-IMMUNO PLATE; Thermo Fisher Scientific Inc., Rochester, NY, USA). The monoclonal antibody 37-11 or 77-3, previously conjugated to HRP using a Peroxidase Labeling Kit-SH (Dojindo Molecular Technologies Inc., Kumamoto, Japan), was used as a primary antibody. The substrate SIGMAFAST OPD (Sigma-Aldrich, St. Louis, MO) was used for color development according to the manufacturer’s instructions. For sandwich ELISA, the antibody 77-3 was used as the primary antibody, and HRP-conjugated antibody 37-11 was used as the secondary antibody as described previously [<xref ref-type="bibr" rid="scirp.69947-ref13">13</xref>] .</p></sec><sec id="s2_3"><title>2.3. Atomic Force Microscopy</title><p>The sizes and shapes of the aggregates were observed by atomic force microscopy (AFM, JSPM-5200, JEOL Ltd, Tokyo, Japan) as previously described [<xref ref-type="bibr" rid="scirp.69947-ref12">12</xref>] . The aggregates (10 μl) were dropped on fresh mica and dried by desiccation, and measured using the altering current mode at room temperature, with a frequency of approximately 190 kHz, typical of resonances with a 4.5 N/m spring constant.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Cu<sup>2+</sup> Increases Signal Intensity of Soluble Aggregates during Sandwich ELISA</title><p>Metal ions are known to bind to Aβ and induce the formation of the amorphous aggregates. Metal ions were hypothesized to change the conformation of the epitopes, recognized by antibodies 37-11 and 77-3, and used for the highly sensitive detection of soluble aggregates. Various metal ions (50 μM MnCl<sub>2</sub>, FeCl<sub>2</sub>, NiCl<sub>2</sub>, CuCl<sub>2</sub>, or ZnCl<sub>2</sub>) were added to the soluble aggregates and signal intensities were observed after sandwich ELISA using the two antibodies. The addition of CuSO<sub>4</sub> increased the signal intensity approximately 9.1-fold; however, the effect of other metal ions had little effect on signal intensities (data not shown). This result is consistent with the previous reports suggesting that binding of Cu<sup>2+</sup> to Aβ is stronger than that of other metal ions. Thus, the increased signal intensity was considered to be caused by Cu<sup>2+</sup> binding to Aβ The effect of different concentrations of CuSO<sub>4</sub> on the signal intensity of soluble aggregates in the sandwich ELISA is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. The signal increased in the presence of 10 μM CuSO<sub>4</sub>, and reached a maximum in the presence of CuSO<sub>4</sub> ranging in concentration from 25 to 75 μM. These concentrations of Cu<sup>2+</sup> were much higher than those of Aβ (130 nM in 100 μl), used for the ELISA, and may have induced the formation of amorphous aggregates. Some studies have shown that Cu<sup>2+</sup> at sub-equimolar metal ion/Aβ<sub>42</sub> ratios induces the formation of fibrils, whereas supra-molar ratios induce the formation of non-fibrillar forms [<xref ref-type="bibr" rid="scirp.69947-ref15">15</xref>] . In addition, the Cu<sup>2+</sup> concentrations in this report were similar to those found in the serum (7 - 41 μM) [<xref ref-type="bibr" rid="scirp.69947-ref22">22</xref>] . <xref ref-type="fig" rid="fig2">Figure 2</xref> shows the effects of CuSO<sub>4</sub> and CuCl<sub>2</sub> on the signal intensities of the sandwich ELISA. The effect of CuCl<sub>2</sub> was greater than that of CuSO<sub>4</sub> suggesting that the counter anion also affects signal intensity.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Effect of CuSO<sub>4</sub> concentrations on the signal intensity of the sandwich ELISA. Sandwich ELISA was performed using the antibody 77-3 as a primary antibody and HRP-conjugated antibody 37-11 as a secondary antibody. The reactivity of the soluble aggregates (13 pmol), in the presence and absence of various concentrations of Cu<sup>2+</sup>, was determined</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-7301220x2.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Effect of CuSO<sub>4</sub> and CuCl<sub>2</sub> on the signal intensity of the sandwich ELISA. Sandwich ELISA using the antibodies 37-11 and 77-3 was performed in the absence (circles) and presence of 50 μM CuSO<sub>4</sub> (triangles) or CuCl<sub>2</sub> (squares)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-7301220x3.png"/></fig></sec><sec id="s3_2"><title>3.2. Cu<sup>2+</sup> Has Little Effect on the Signal Intensity of the Soluble Aggregates from Direct ELISA</title><p>It is possible that the epitopes, recognized by antibodies 37-11 and 77-3, are formed on the surface of soluble aggregates in the presence of Cu<sup>2+</sup>. To evaluate the formation of new epitopes, direct ELISA was performed. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows the effect of 50 μM CuCl<sub>2</sub> on signal intensities. Unlike the results of the sandwich ELISA (<xref ref-type="fig" rid="fig2">Figure 2</xref>), Cu<sup>2+ </sup>only minimally enhanced the signal intensity. These results suggest that Cu<sup>2+</sup> increases the intensity by gathering distinct aggregates with two distinct epitopes recognized by antibodies 37-11 and 77-3, rather than generating these epitopes. The AFM images (<xref ref-type="fig" rid="fig4">Figure 4</xref>), showing the formation of larger aggregates through the addition of Cu<sup>2+</sup>, were</p><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title>Effect of CuCl<sub>2</sub> on the signal intensity of the direct ELISA. Direct ELISA using HRP-conjugated antibody 37-11 (a) or 77-3 (b) was performed in the absence (open squares) and the presence of 50 μM CuCl<sub>2</sub> (closed circles).</title></caption><fig id ="fig3_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-7301220x4.png"/></fig></fig-group><fig-group id="fig4"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> AFM images of soluble aggregates. Soluble aggregates in the absence (a) and presence (b) of 50 μM CuCl<sub>2</sub> are shown.</title></caption><fig id ="fig4_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-7301220x5.png"/></fig></fig-group><p>consistent with this theory. Based on this hypothesis, the epitopes recognized by antibodies 37-11 and 77-3 might be separately located on the surface of distinct aggregates, and few aggregates have both epitopes on their surface.</p><p>This report shows that the addition of Cu<sup>2+</sup> increases the reactivity of the sandwich ELISA for soluble aggregates. This finding could contribute to the development of a precise and highly sensitive ELISA for Aβ aggregates by enhancing the reactivity of the antibodies.</p></sec></sec><sec id="s4"><title>Cite this paper</title><p>Itakura, A., Kanematsu, Y.F., Suzuki, R., Kohno, H. and Yo- shimune, K. (2016) Copper Ions Enhance Signal Intensity of Sandwich ELISA for Amorphous Aggregates of Amyloid-β<sub>42</sub>. Adv- ances in Bioscience and Biotechnology, 7, 343-349. http://dx.doi.org/10.4236/abb.2016.79033</p></sec></body><back><ref-list><title>References</title><ref id="scirp.69947-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Awasthi, M., Singh, S., Pandey, V.P. and Dwivedi, U.N. (2016) Alzheimer’s Disease: An Overview of Amyloid Beta Dependent Pathogenesis and Its Therapeutic Implications along with In Silico Approaches Emphasizing the Role of Natural Products. Journal of Neurological Sciences, 361, 256-271. http://dx.doi.org/10.1016/j.jns.2016.01.008</mixed-citation></ref><ref id="scirp.69947-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Hardy, J.A. and Higgins, G.A. (1992) Alzheimer’s Disease: The Amyloid Cascade Hypothesis. Science, 256, 184-185. http://dx.doi.org/10.1126/science.1566067</mixed-citation></ref><ref id="scirp.69947-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">vanOijen, M., Hofman, A., Soares, H.D., Koudstaal, P.J. and Breteler, M.M. (2006) Plasma Abeta(1-40) and Abeta(1-42) and the Risk of Dementia: A Prospective Case-Cohort Study. Lancet Neurology, 5, 655-660. http://dx.doi.org/10.1016/S1474-4422(06)70501-4</mixed-citation></ref><ref id="scirp.69947-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, N., Cheung, T.T., Cai, X.D., Odaka. A., Otvos, L. Jr., Eckman, C., Golde, T.E. and Younkin, S.G. (1994) An Increased Percentage of Long Amyloid Beta Protein Secreted by Familial Amyloid Beta Protein Precursor (Beta APP717) Mutants. Science, 264, 1336-1340. http://dx.doi.org/10.1126/science.8191290</mixed-citation></ref><ref id="scirp.69947-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chimon, S., Shaibat, M.A., Jones, C.R., Calero, D.C., Aizezi, B. and Ishii, Y. (2007) Evidence of Fibril-Like β-Sheet Structures in a Neurotoxic Amyloid Intermediate of Alzheimer’s β-Amyloid. Nature Structural &amp; Molecular Biology, 14, 1157-1164. http://dx.doi.org/10.1038/nsmb1345</mixed-citation></ref><ref id="scirp.69947-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">O'Nuallain, B., Freir, D.B., Nicoll, A.J., Risse, E., Ferguson, N., Herron, C.E., Collinge, J. and Walsh, D.M. (2010) Amyloid Beta-Protein Dimers Rapidly Form Stable Synaptotoxicprotofibrils. The Journal of Neuroscience, 30, 14411-14419. http://dx.doi.org/10.1523/JNEUROSCI.3537-10.2010</mixed-citation></ref><ref id="scirp.69947-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dickson, D.W. (1997) The Pathogenesis of Senile Plaques. Journal of Neuropathology &amp; Experimental Neurology, 56, 1285-1290. http://dx.doi.org/10.1097/00005072-199704000-00001</mixed-citation></ref><ref id="scirp.69947-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ochiishi, T., Itakura, A., Liu, L., Akatsu, H., Kohno, H., Nishimura, M. and Yoshimune, K. (2016) Immunohistochemical Detection of the Delayed Formation of Nonfibrillar Large Amyloid-β Aggregates. Genes Cells, 21, 200-211. http://dx.doi.org/10.1111/gtc.12332</mixed-citation></ref><ref id="scirp.69947-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L. and other 5 authors (1998) Diffusible, Nonfibrillar Ligands Derived from Abeta1-42 Are Potent Central Nervous System Neurotoxins. The Proceedings of the National Academy of Sciences of the United States of America, 95, 6448-6453. http://dx.doi.org/10.1073/pnas.95.11.6448</mixed-citation></ref><ref id="scirp.69947-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Barghorn, S., Nimmrich, V., Striebinger A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R.S., Harlan, J., et al. (2005) Globular Amyloid Beta-Peptide Oligomer —A Homogenous and Stable Neuropathological Protein in Alzheimer’s Disease. Journal of Neurochemistry, 95, 834-847. http://dx.doi.org/10.1111/j.1471-4159.2005.03407.x</mixed-citation></ref><ref id="scirp.69947-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Matsumura, S., Shinoda, K., Yamada, M., Yokojima, S., Inoue, M., Ohnishi, T., Shimada, T., Kikuchi, K., Masui, D., Hashimoto, S. and other 14 authors (2011) Two Distinct Amyloid Beta-Protein (Abeta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses. Journal of Biological Chemistry, 286, 11555-11562. http://dx.doi.org/10.1074/jbc.M110.181313</mixed-citation></ref><ref id="scirp.69947-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, T., Yoshimune, K., Komoriya, T., Akiyama, T., Ye, X. and Kohno, H. (2013) Monoclonal Antibodies against Large Oval Aggregates of Aβ1-42. Journal of Bioscience and Bioengineering 115, 216-220. http://dx.doi.org/10.1016/j.jbiosc.2012.09.007</mixed-citation></ref><ref id="scirp.69947-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, T., Yoshimune, K., Komoriya, T., Akiyama, T., Ye, X. and Kohno, H. (2013) Combination of Specific Monoclonal Antibodies Allow Identification of Soluble Aggregates of Aβ1-42 by Sandwich ELISA. Advances in Bioscience and Biotechnology, 4, 63-66. http://dx.doi.org/10.4236/abb.2013.44A009</mixed-citation></ref><ref id="scirp.69947-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Branch, T., Girvan, P., Barahona, M. and Ying, L. (2015) Introduction of a Fluorescent Probe to Amyloid-β to Reveal Kinetic Insights into Its Interactions with Copper(II). Angewandte Chemie International Edition, 54, 1227-1230. http://dx.doi.org/10.1002/anie.201408810</mixed-citation></ref><ref id="scirp.69947-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ryan, T.M., Kirby, N., Mertens, H.D., Roberts, B., Barnham, K.J., Cappai, R., Pham, Cle L., Masters, C.L. and Curtain, C.C. (2015) Small Angle X-Ray Scattering Analysis of Cu(2+)-Induced Oligomers of the Alzheimer’s Amyloid β Peptide. Metallomics, 7, 536-543. http://dx.doi.org/10.1039/C4MT00323C</mixed-citation></ref><ref id="scirp.69947-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, D., Rauda, I., Han, S., Chen, S. and Zhou, F. (2012) Aggregation Pathways of the Amyloid β(1-42) Peptide Depend on Its Colloidal Stability and Ordered β-Sheet Stacking. Langmuir, 28, 12711-12721. http://dx.doi.org/10.1021/la3021436</mixed-citation></ref><ref id="scirp.69947-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Shimanouchi, T., Onishi, R., Kitaura, N., Umakoshi, H. and Kuboi, R. (2011) Copper-Mediated Growth of Amyloid β Fibrils in the Presence of Oxidized and Negatively Charged Liposomes. Journal of Bioscience and Bioengineering, 112, 611-615. http://dx.doi.org/10.1016/j.jbiosc.2011.08.015</mixed-citation></ref><ref id="scirp.69947-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tougu, V., Karafin, A., Zovo, K., Chung, R.S., Howells, C., West, A.K. and Palumaa, P. (2009) Zn(II)- and Cu(II)-Induced Non-Fibrillar Aggregates of Amyloid-Beta (1-42) Peptide Are Transformed to Amyloid Fibrils, Both Spontaneously and Under the Influence of Metal Chelators. Journal of Neurochemistry, 110, 1784-1795. http://dx.doi.org/10.1111/j.1471-4159.2009.06269.x</mixed-citation></ref><ref id="scirp.69947-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Blennow, K., Mattsson, N., Scholl, M., Hansson, O. and Zetterberg, H. (2015) Amyloid Biomarkers in Alzheimer’s Disease. Trends in Pharmacological Sciences, 36, 297-309. http://dx.doi.org/10.1016/j.tips.2015.03.002</mixed-citation></ref><ref id="scirp.69947-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Holtta, M., Hansson, O., Andreasson, U., Hertze, J., Minthon, L., Nagga, K., Andreasen, N., Zetterberg, H. and Blennow, K. (2013) Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease. PLoS One, 8, e66381. http://dx.doi.org/10.1371/journal.pone.0066381</mixed-citation></ref><ref id="scirp.69947-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, T., Yoshimune, K., Komoriya, T., Ogawa, M., Akiyama, T., Ye, X. and Kohno, H. (2015) Classification of Monoclonal Antibodies to Measure the Progress of Aβ1-42 Aggregation. Global Journal for Research Analysis, 4, 117-119.</mixed-citation></ref><ref id="scirp.69947-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Twomey, P.J., Viljoen, A., House, I.M., Reynolds, T.M. and Wierzbicki, A.S. (2005) Relationship between Serum Copper, Ceruloplasmin, and Non-Ceruloplasmin-Bound Copper in Routine Clinical Practice. Clinical Chemistry, 51, 1558-1559. http://dx.doi.org/10.1373/clinchem.2005.052688</mixed-citation></ref></ref-list></back></article>